Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01361048 · ClinicalTrials.gov registry record · Phase 2
Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT01361048: Completed Phase 2 study, sponsored by University of Alabama at Birmingham.
NCT01361048 is a Phase 2 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01361048, a Phase 2 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The investigators are trying a combination vaginal product of higher dose metronidazole combined with miconazole to see if it is effective in treating vaginal trichomonas.
Primary Outcome
percentage of participants achieving microbiological cure of trichomonas
Interventions
- DRUG oral metronidazole
- DRUG neo penotran forte
- DRUG neo penotran forte once a day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-01 |
| Phase | Phase 2 |
What the finished NCT01361048 record still lists
NCT01361048 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 3 interventions - of which oral metronidazole is the first listed.
NCT01361048 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01361048 about?
NCT01361048 is a clinical study titled "Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis". The investigators are trying a combination vaginal product of higher dose metronidazole combined with miconazole to see if it is effective in treating vaginal trichomonas.
What is the current status of trial NCT01361048?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2011-12. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01361048?
The interventions under investigation include: oral metronidazole (DRUG), neo penotran forte (DRUG), neo penotran forte once a day (DRUG).
Who is sponsoring clinical trial NCT01361048?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01361048's enrollment target sits among peer trials
40 1362nd of 2000 higher than 542 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia